FR2943248B1 - USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS - Google Patents

USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS

Info

Publication number
FR2943248B1
FR2943248B1 FR0951694A FR0951694A FR2943248B1 FR 2943248 B1 FR2943248 B1 FR 2943248B1 FR 0951694 A FR0951694 A FR 0951694A FR 0951694 A FR0951694 A FR 0951694A FR 2943248 B1 FR2943248 B1 FR 2943248B1
Authority
FR
France
Prior art keywords
disorders
treatment
scalp
wolfberry extract
leather
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0951694A
Other languages
French (fr)
Other versions
FR2943248A1 (en
Inventor
Isabelle Castiel
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Priority to FR0951694A priority Critical patent/FR2943248B1/en
Priority to PCT/IB2010/051034 priority patent/WO2010103472A1/en
Priority to EP10710670.0A priority patent/EP2405926B1/en
Priority to ES10710670.0T priority patent/ES2596602T3/en
Priority to BRPI1008985-3A priority patent/BRPI1008985B1/en
Publication of FR2943248A1 publication Critical patent/FR2943248A1/en
Application granted granted Critical
Publication of FR2943248B1 publication Critical patent/FR2943248B1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/006—Antidandruff preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair

Abstract

La présente invention concerne l'utilisation d'une quantité efficace d'un extrait de Wolfberry, et notamment de Lactowolfberry, pour prévenir et/ou traiter les désordres pelliculaires du cuir chevelu.The present invention relates to the use of an effective amount of an extract of Wolfberry, and in particular of Lactowolfberry, for preventing and / or treating dandruff disorders of the scalp.

FR0951694A 2009-03-11 2009-03-17 USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS Expired - Fee Related FR2943248B1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0951694A FR2943248B1 (en) 2009-03-17 2009-03-17 USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS
PCT/IB2010/051034 WO2010103472A1 (en) 2009-03-11 2010-03-10 Cosmetic use of an extract of wolfberry for treating scalp disorders
EP10710670.0A EP2405926B1 (en) 2009-03-11 2010-03-10 Cosmetic use of an extract of wolfberry for treating scalp disorders
ES10710670.0T ES2596602T3 (en) 2009-03-11 2010-03-10 Cosmetic use of a goji berry extract to treat scalp disorders
BRPI1008985-3A BRPI1008985B1 (en) 2009-03-11 2010-03-10 COSMETIC USE OF AN EFFECTIVE QUANTITY OF A SYNPHININE EXTRACT, COSMETIC AND / OR DERMATOLOGICAL COMPOSITION, AND COSMETIC METHOD FOR TRAINING AND / OR PREVENTING AESTHETIC DISORDERS IN AN INDIVIDUAL.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0951694A FR2943248B1 (en) 2009-03-17 2009-03-17 USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS

Publications (2)

Publication Number Publication Date
FR2943248A1 FR2943248A1 (en) 2010-09-24
FR2943248B1 true FR2943248B1 (en) 2012-09-28

Family

ID=41037861

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0951694A Expired - Fee Related FR2943248B1 (en) 2009-03-11 2009-03-17 USE OF A WOLFBERRY EXTRACT FOR THE TREATMENT OF SCALP LEATHER DISORDERS

Country Status (1)

Country Link
FR (1) FR2943248B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022144509A1 (en) * 2021-01-04 2022-07-07 Idec Therapeutic Composition comprising at least one probiotic, at least one antioxidant and polysaccharides from adaptogenic plant(s)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250399B1 (en) * 1985-12-20 1988-11-17 INNOFINANCE Altalános Innovácios Pénzintézet Skin care compositions having keratolytic and antiinflammatory activity
KR20020029455A (en) * 2000-10-13 2002-04-19 황인명 making method of good food for the head skin and health
EP1616551A1 (en) * 2004-07-13 2006-01-18 L'oreal Cosmetic treatment for preventing or delaying the signs of skin ageing
WO2008067315A1 (en) * 2006-11-28 2008-06-05 Renaissance Herbs, Inc. Therapeutic composition from goji (lycium barbarum l.), methods of making and using
FR2920304B1 (en) * 2007-09-04 2010-06-25 Oreal COSMETIC USE OF LYSAT BIFIDOBACTERIUM SPECIES FOR THE TREATMENT OF DROUGHT.
KR100822835B1 (en) * 2007-10-22 2008-04-16 주식회사 사임당화장품 Plant extracts and cosmetic compositions for improvement of scalp and hair

Also Published As

Publication number Publication date
FR2943248A1 (en) 2010-09-24

Similar Documents

Publication Publication Date Title
FR2938437B1 (en) COSMETIC USE OF MICROORGANISM FOR THE TREATMENT OF OILY SKIN
EA201071243A1 (en) COMBINED COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISEASES WITH ZONISSMID AND ACAPROSAT
WO2011022606A3 (en) Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
EA201891833A1 (en) COMBINATION FOR THE TREATMENT OF AMIOTROPHIC SIDE SCLEROSIS OR RELATED DISEASES
FR2948565B1 (en) COSMETIC COMPOSITION FOR THE TREATMENT OF ACNE COMPRISING A PETIDIC EXTRACT FROM SCHIZANDRA
EA201071245A1 (en) NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF ALZGEYMER'S DISEASE AND RELATED DISTURBANCES THROUGH MODULATION OF THE STRESS RESPONSE
MA34726B1 (en) PREVENTING SIDE EFFECTS CAUSED BY SPECIFIC CD3 LINKAGE DOMAINS
EA201290677A1 (en) CONNECTIONS OF REVERSE AMIDA AS PROTIN-DEACETYLASE INHIBITORS AND METHODS
MA35638B1 (en) 2-thiopyrimidinones
TW200730624A (en) Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human CD38
FR2959128B1 (en) COSMETIC USE OF A SPECIFIC BIFIDOBACTERIUM LYSATE FOR THE TREATMENT OF BODY ODORS
MX2011009752A (en) Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1.
TN2016000040A1 (en) PORC2 INHIBITORS AND METHODS FOR THEIR USE
FR2930153B1 (en) USE OF A BAY EXTRACT, AND ESPECIALLY WOLFBERRY, FOR THE TREATMENT OF DROUGHT KERATINIC MATTER
WO2011082409A3 (en) Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
FR2984743B1 (en) COSMETIC USE OF STEVIOL, STEVIOL GLYCOSIDE DERIVATIVE, OR ONE OF THEIR ISOMERS FOR STIMULATING, RESTORING OR REGULATING METABOLISM OF SKIN CELLS AND SEMI-MUCOUS MEMBRANES
WO2012058268A3 (en) Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
FR2943249B1 (en) USE OF DECORINE TO INCREASE MUSCLE MASS
EA201391591A1 (en) TREATMENT OF MULTIPLE MYELOMA
WO2012047956A3 (en) Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
MX2017006464A (en) Tlr inhibitor and bruton's tyrosine kinase inhibitor combinations.
MA35895B1 (en) Iap inhibitors
FR2939030B1 (en) USE OF TAURINE FOR THE TREATMENT OF CANITIA
FR3042710B1 (en) COMPOSITION BASED ON DIHYDROMYRICETIN AND ZINC SALT FOR THE TREATMENT OF ACNE AND OILY SKIN
MA38253A1 (en) Compositions comprising vortioxetine and donepezil

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

TQ Partial transmission of property

Owner name: SOCIETE DES PRODUITS NESTLE S.A., CH

Effective date: 20190919

Owner name: L'OREAL, FR

Effective date: 20190919

PLFP Fee payment

Year of fee payment: 12

ST Notification of lapse

Effective date: 20211105